These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 11213859)
1. Dosing and monitoring of low-molecular-weight heparins in special populations. Duplaga BA; Rivers CW; Nutescu E Pharmacotherapy; 2001 Feb; 21(2):218-34. PubMed ID: 11213859 [TBL] [Abstract][Full Text] [Related]
2. Safety profile of different low-molecular weight heparins used at therapeutic dose. Gouin-Thibault I; Pautas E; Siguret V Drug Saf; 2005; 28(4):333-49. PubMed ID: 15783242 [TBL] [Abstract][Full Text] [Related]
3. How and when to monitor a patient treated with low molecular weight heparin. Boneu B; de Moerloose P Semin Thromb Hemost; 2001 Oct; 27(5):519-22. PubMed ID: 11668422 [TBL] [Abstract][Full Text] [Related]
4. Deep venous thrombosis and pulmonary embolism. Part 1. Initial treatment: usually a low-molecular-weight heparin. Prescrire Int; 2013 Apr; 22(137):99-101, 103-4. PubMed ID: 23662321 [TBL] [Abstract][Full Text] [Related]
5. Low-molecular-weight heparins in renal impairment and obesity: available evidence and clinical practice recommendations across medical and surgical settings. Nutescu EA; Spinler SA; Wittkowsky A; Dager WE Ann Pharmacother; 2009 Jun; 43(6):1064-83. PubMed ID: 19458109 [TBL] [Abstract][Full Text] [Related]
6. Low molecular weight heparins: are they superior to unfractionated heparins to prevent and to treat deep vein thrombosis? Boneu B Thromb Res; 2000 Oct; 100(2):V113-20. PubMed ID: 11053624 [TBL] [Abstract][Full Text] [Related]
7. Low-molecular-weight heparins in the treatment of deep-vein thrombosis. Martineau P; Tawil N Ann Pharmacother; 1998 May; 32(5):588-98, 601. PubMed ID: 9606481 [TBL] [Abstract][Full Text] [Related]
8. [Treatment and prophylaxis of deep venous thrombosis with low molecular weight heparins (meta-analysis of clinical trials)]. Valiukiene L; Naudziūnas A; Unikauskas A Medicina (Kaunas); 2003; 39(4):352-8. PubMed ID: 12738903 [TBL] [Abstract][Full Text] [Related]
9. [Therapeutic indications of low molecular weight heparins]. Samama MM; Michaut-Paterno F Arch Mal Coeur Vaiss; 1991 Nov; 84(11 Suppl):1733-43. PubMed ID: 1662941 [TBL] [Abstract][Full Text] [Related]
10. Differentiation of low molecular weight heparins in treatment of acute deep vein thrombosis. Davidson BL Semin Thromb Hemost; 1999; 25 Suppl 3():107-12. PubMed ID: 10549725 [TBL] [Abstract][Full Text] [Related]
12. Heparin and low molecular weight heparin: background and pharmacology. Morris TA Clin Chest Med; 2003 Mar; 24(1):39-47. PubMed ID: 12685055 [TBL] [Abstract][Full Text] [Related]
13. Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Hirsh J; Raschke R Chest; 2004 Sep; 126(3 Suppl):188S-203S. PubMed ID: 15383472 [TBL] [Abstract][Full Text] [Related]
14. The safety and efficacy of use of low-molecular-weight heparin in pediatric neurosurgical patients. Gonda DD; Fridley J; Ryan SL; Briceño V; Lam SK; Luerssen TG; Jea A J Neurosurg Pediatr; 2015 Sep; 16(3):329-34. PubMed ID: 26067336 [TBL] [Abstract][Full Text] [Related]
15. Bemiparin: a review of its use in the prevention of venous thromboembolism and treatment of deep vein thrombosis. Chapman TM; Goa KL Drugs; 2003; 63(21):2357-77. PubMed ID: 14524738 [TBL] [Abstract][Full Text] [Related]
16. Low-molecular weight heparins in venous and arterial thrombotic disease. Bijsterveld NR; Hettiarachchi R; Peters R; Prins MH; Levi M; Büller HR Thromb Haemost; 1999 Sep; 82 Suppl 1():139-47. PubMed ID: 10695506 [TBL] [Abstract][Full Text] [Related]